Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy

Jack Kingdon; Adam M Gwozdz; Rachael Morris; Stephen A Black; Alberto Smith; Prakash Saha

doi:10.1080/17434440.2020.1748009

Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy

Jack Kingdon, Adam M Gwozdz, Rachael Morris, Stephen A Black, Alberto Smith, Prakash Saha

Vascular Risk & Surgery

Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Sciences, BHF Centre of Research Excellence, Guy's and St. Thomas' NHS Trust, King's College London, London, UK.

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Introduction: Endovenous stenting is being increasingly used for the management of iliofemoral venous outflow obstruction due to thrombotic or non-thrombotic iliac vein lesions (NIVL). Dedicated venous stents have replaced re-purposed arterial stents but there are limited data on their relative safety and efficacy.Areas covered: This review looks at the available literature on the safety and efficacy of the Veniti Vici Venous stent (Boston Scientific), a specific venous stent, and compares its outcomes with the other venous stents that are currently available. Reported outcomes include patency, clinical efficacy, and the number of adverse events.Expert opinion: The initial clinical trials of the Vici venous stent have shown both good clinical and safety outcomes at 12-24 months follow-up. Longer follow-up data are pending and further trials comparing available stents are required. Current evidence supports its use in the management of deep venous reconstruction, especially in occlusive post-thrombotic disease. Patients should, however, be made aware of the paucity of long-term data and the need for monitoring within a dedicated surveillance program following stent placement.

Original language	English
Pages (from-to)	391-397
Number of pages	7
Journal	Expert Review Of Medical Devices
Volume	17
Issue number	5
Early online date	21 Apr 2020
DOIs	https://doi.org/10.1080/17434440.2020.1748009
Publication status	Published - 3 May 2020

Keywords

Deep vein thrombosis
Stent
endovascular surgery
post thrombotic syndrome
venous reconstruction
venous stent

Access to Document

10.1080/17434440.2020.1748009

Cite this

@article{aaa77b8caf60409bb7a6d3ea725a0601,

title = "Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy",

abstract = "Introduction: Endovenous stenting is being increasingly used for the management of iliofemoral venous outflow obstruction due to thrombotic or non-thrombotic iliac vein lesions (NIVL). Dedicated venous stents have replaced re-purposed arterial stents but there are limited data on their relative safety and efficacy.Areas covered: This review looks at the available literature on the safety and efficacy of the Veniti Vici Venous stent (Boston Scientific), a specific venous stent, and compares its outcomes with the other venous stents that are currently available. Reported outcomes include patency, clinical efficacy, and the number of adverse events.Expert opinion: The initial clinical trials of the Vici venous stent have shown both good clinical and safety outcomes at 12-24 months follow-up. Longer follow-up data are pending and further trials comparing available stents are required. Current evidence supports its use in the management of deep venous reconstruction, especially in occlusive post-thrombotic disease. Patients should, however, be made aware of the paucity of long-term data and the need for monitoring within a dedicated surveillance program following stent placement.",

keywords = "Deep vein thrombosis, Stent, endovascular surgery, post thrombotic syndrome, venous reconstruction, venous stent",

author = "Jack Kingdon and Gwozdz, {Adam M} and Rachael Morris and Black, {Stephen A} and Alberto Smith and Prakash Saha",

year = "2020",

month = may,

day = "3",

doi = "10.1080/17434440.2020.1748009",

language = "English",

volume = "17",

pages = "391--397",

journal = "Expert Review Of Medical Devices",

issn = "1743-4440",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization

T2 - overview of its safety and efficacy

AU - Kingdon, Jack

AU - Gwozdz, Adam M

AU - Morris, Rachael

AU - Black, Stephen A

AU - Smith, Alberto

AU - Saha, Prakash

PY - 2020/5/3

Y1 - 2020/5/3

N2 - Introduction: Endovenous stenting is being increasingly used for the management of iliofemoral venous outflow obstruction due to thrombotic or non-thrombotic iliac vein lesions (NIVL). Dedicated venous stents have replaced re-purposed arterial stents but there are limited data on their relative safety and efficacy.Areas covered: This review looks at the available literature on the safety and efficacy of the Veniti Vici Venous stent (Boston Scientific), a specific venous stent, and compares its outcomes with the other venous stents that are currently available. Reported outcomes include patency, clinical efficacy, and the number of adverse events.Expert opinion: The initial clinical trials of the Vici venous stent have shown both good clinical and safety outcomes at 12-24 months follow-up. Longer follow-up data are pending and further trials comparing available stents are required. Current evidence supports its use in the management of deep venous reconstruction, especially in occlusive post-thrombotic disease. Patients should, however, be made aware of the paucity of long-term data and the need for monitoring within a dedicated surveillance program following stent placement.

AB - Introduction: Endovenous stenting is being increasingly used for the management of iliofemoral venous outflow obstruction due to thrombotic or non-thrombotic iliac vein lesions (NIVL). Dedicated venous stents have replaced re-purposed arterial stents but there are limited data on their relative safety and efficacy.Areas covered: This review looks at the available literature on the safety and efficacy of the Veniti Vici Venous stent (Boston Scientific), a specific venous stent, and compares its outcomes with the other venous stents that are currently available. Reported outcomes include patency, clinical efficacy, and the number of adverse events.Expert opinion: The initial clinical trials of the Vici venous stent have shown both good clinical and safety outcomes at 12-24 months follow-up. Longer follow-up data are pending and further trials comparing available stents are required. Current evidence supports its use in the management of deep venous reconstruction, especially in occlusive post-thrombotic disease. Patients should, however, be made aware of the paucity of long-term data and the need for monitoring within a dedicated surveillance program following stent placement.

KW - Deep vein thrombosis

KW - Stent

KW - endovascular surgery

KW - post thrombotic syndrome

KW - venous reconstruction

KW - venous stent

UR - http://www.scopus.com/inward/record.url?scp=85083692664&partnerID=8YFLogxK

U2 - 10.1080/17434440.2020.1748009

DO - 10.1080/17434440.2020.1748009

M3 - Article

C2 - 32223356

SN - 1743-4440

VL - 17

SP - 391

EP - 397

JO - Expert Review Of Medical Devices

JF - Expert Review Of Medical Devices

IS - 5

ER -

Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this